FedEx Corporation vs Novartis AG — how do they compare? FedEx Corporation trades at $322.99 (market cap $76.28B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 3.9× FedEx Corporation's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| FDX | NVS | |
|---|---|---|
Market Cap | $76.28B | $295.37B |
Sector | Industrials | Health |
52-Week High | $338.75 | $168.62 |
52-Week Low | $180.51 | $119.31 |
Enterprise Value | $105.91B | $336.69B |
Dividend Yield | 1.51% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →